
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.870 | 1.870 | 0.000 |
Shares | 98.130 | 98.130 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.311 | 20.121 |
Price to Book | 4.043 | 3.959 |
Price to Sales | 2.065 | 2.371 |
Price to Cash Flow | 14.987 | 15.981 |
Dividend Yield | 2.023 | 1.394 |
5 Years Earnings Growth | 10.095 | 11.538 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.440 | 94.343 |
Consumer Cyclical | 0.560 | 8.310 |
Number of long holdings: 57
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.68 | 755.57 | +2.86% | |
J&J | US4781601046 | 5.38 | 154.16 | -0.04% | |
AbbVie | US00287Y1091 | 5.35 | 190.07 | +2.96% | |
UnitedHealth | US91324P1021 | 4.86 | 378.81 | -0.48% | |
AstraZeneca | GB0009895292 | 3.15 | 10,272.0 | +0.31% | |
Amgen | US0311621009 | 3.13 | 274.76 | +3.35% | |
Merck&Co | US58933Y1055 | 3.12 | 80.43 | +5.87% | |
Novo Nordisk B | DK0062498333 | 3.10 | 441.4 | -0.65% | |
Thermo Fisher Scientific | US8835561023 | 3.08 | 432.59 | +7.31% | |
Novartis | CH0012005267 | 2.91 | 91.68 | +0.85% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -6.78 | - | ||
FIM Emerging markets ESG | 431.72M | -1.47 | 0.32 | 1.46 | ||
S SaastOrahasto Kohtuullinen | 312.2M | -5.16 | 3.90 | 4.17 | ||
S-Saastorahasto Rohkea | 293.57M | -7.27 | 5.12 | 5.96 | ||
FIM USA | 250.97M | -13.97 | 8.47 | 9.29 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review